share price:

10430

Gedeon Richter is a specialised, innovation-driven pharmaceutical company committed to supporting society in the fight against disease by developing and delivering modern therapies.

Learn more

A specialised pharmaceutical company
Gedeon Richter’s strategic objective is to strengthen its position among Europe’s leading mid-sized pharmaceutical companies.

Areas of Expertise

Areas of Activity

Gedeon Richter focuses on creating high value-added products, basing its strategy on innovative research and placing a strong emphasis on women’s health and the development of biosimilar medicines.

Learn more

Research into new molecules has always been at the core of Gedeon Richter’s corporate strategy. The company’s research and development centre, employing more than 1,200 people, makes it the leading pharmaceutical research hub in Central and Eastern Europe.

Our Products

Gedeon Richter’s portfolio includes over 200 original, generic and licensed therapies used across a wide range of therapeutic areas. The company focuses on developing and manufacturing medicines used in the treatment of disorders of the nervous system, cardiovascular diseases and gynaecology.

Learn more

Thanks to its in-house production of active pharmaceutical ingredients and a broad product portfolio, Richter delivers innovative therapeutic solutions for women of all ages and   with diverse health needs.

Sustainability

At Gedeon Richter, we continuously pursue innovation. At the same time, we believe that through conscious and responsible actions, we can meet the needs of today’s generations while maintaining the trust of those to come.

Learn more

We are proud that Gedeon Richter represents not only innovative products, but also a stable and supportive workplace guided by the principles of sustainable development.

Contact

If you have any questions, please contact us using the appropriate telephone number or email address.

If you have not found the information you were looking for on our website or have additional questions, we encourage you to get in touch with us.

Amlator

Układ krążenia Układ nerwowy Cardiology Gynaecology and endocrinology Neurology Infectious diseases Musculoskeletal system Urology Gastroenterology Dermatology Psychiatry

Active substance:

Atorvastatinum, Amlodipinum

Dosage:

10 mg + 10 mg

Therapeutic area:

Cardiology

Pharmaceutical form:

Coated tablets

Product category:

Na receptę

Refund:

Brochure Amlator

Driving a car

Yes

Breast feeding

Taking on an empty stomach

Yes

Drug storage

Przechowywać w opakowaniu w celu ochrony przed światłem i wilgocią, w temp. poniżej 25

Download full drug leaflet

PDF

According to the World Health Organisation, heart and circulatory diseases are the most common causes of deaths in developed countries, while arterial hypertension – which is an extremely dangerous and chronic disease – is the most common condition affecting the circulatory system.

See other products from the area

About us

Areas of Activity

Our Products

Sustainability

Contact

Amlator

Brochure Amlator

Cardiology

Identity confirmation

Charakterystyka produktu leczniczego

Amlator

Do pobrania

Brochure Amlator

Cardiology

Identity confirmation

Charakterystyka produktu leczniczego